609 related articles for article (PubMed ID: 25948625)
1. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Cortese M; Riise T; Bjørnevik K; Holmøy T; Kampman MT; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM
Mult Scler; 2015 Dec; 21(14):1856-64. PubMed ID: 25948625
[TBL] [Abstract][Full Text] [Related]
2. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.
Kampman MT; Wilsgaard T; Mellgren SI
J Neurol; 2007 Apr; 254(4):471-7. PubMed ID: 17377831
[TBL] [Abstract][Full Text] [Related]
3. Cod liver oil intake and incidence of asthma in Norwegian adults--the HUNT study.
Mai XM; Langhammer A; Chen Y; Camargo CA
Thorax; 2013 Jan; 68(1):25-30. PubMed ID: 22977130
[TBL] [Abstract][Full Text] [Related]
4. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study.
Stene LC; Joner G;
Am J Clin Nutr; 2003 Dec; 78(6):1128-34. PubMed ID: 14668274
[TBL] [Abstract][Full Text] [Related]
5. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.
Bjørnevik K; Riise T; Casetta I; Drulovic J; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Lauer K; Lossius A; Magalhaes S; Myhr KM; Pekmezovic T; Wesnes K; Wolfson C; Pugliatti M
Mult Scler; 2014 Jul; 20(8):1042-9. PubMed ID: 24414538
[TBL] [Abstract][Full Text] [Related]
6. Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis.
McDowell TY; Amr S; Culpepper WJ; Langenberg P; Royal W; Bever C; Bradham DD
Neuroepidemiology; 2011; 36(1):39-45. PubMed ID: 21160231
[TBL] [Abstract][Full Text] [Related]
7. Predictors for cod-liver oil supplement use--the Norwegian Women and Cancer Study.
Brustad M; Braaten T; Lund E
Eur J Clin Nutr; 2004 Jan; 58(1):128-36. PubMed ID: 14679378
[TBL] [Abstract][Full Text] [Related]
8. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).
Pugliatti M; Casetta I; Drulovic J; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Lauer K; Myhr KM; Parpinel M; Pekmezovic T; Riise T; Zhu B; Wolfson C
Acta Neurol Scand Suppl; 2012; (195):43-50. PubMed ID: 23278656
[TBL] [Abstract][Full Text] [Related]
9. Childhood cod liver oil consumption and bone mineral density in a population-based cohort of peri- and postmenopausal women: the Nord-Trondelag Health Study.
Forsmo S; Fjeldbo SK; Langhammer A
Am J Epidemiol; 2008 Feb; 167(4):406-11. PubMed ID: 18033763
[TBL] [Abstract][Full Text] [Related]
10. Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial.
Brunvoll SH; Nygaard AB; Ellingjord-Dale M; Holland P; Istre MS; Kalleberg KT; Søraas CL; Holven KB; Ulven SM; Hjartåker A; Haider T; Lund-Johansen F; Dahl JA; Meyer HE; Søraas A
BMJ; 2022 Sep; 378():e071245. PubMed ID: 36215222
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes.
Stene LC; Thorsby PM; Berg JP; Rønningen KS; Joner G;
Pediatr Diabetes; 2008 Feb; 9(1):40-5. PubMed ID: 18211635
[TBL] [Abstract][Full Text] [Related]
12. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.
Wesnes K; Riise T; Casetta I; Drulovic J; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Lauer K; Lossius A; Magalhaes S; Pekmezovic T; Bjørnevik K; Wolfson C; Pugliatti M; Myhr KM
Mult Scler; 2015 Apr; 21(4):388-95. PubMed ID: 25182290
[TBL] [Abstract][Full Text] [Related]
13. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Lossius A; Riise T; Pugliatti M; Bjørnevik K; Casetta I; Drulovic J; Granieri E; Kampman MT; Landtblom AM; Lauer K; Magalhaes S; Myhr KM; Pekmezovic T; Wesnes K; Wolfson C; Holmøy T
Mult Scler; 2014 May; 20(6):669-74. PubMed ID: 24072723
[TBL] [Abstract][Full Text] [Related]
14. Cod liver oil consumption at different periods of life and bone mineral density in old age.
Eysteinsdottir T; Halldorsson TI; Thorsdottir I; Sigurdsson G; Sigurdsson S; Harris T; Launer LJ; Gudnason V; Gunnarsdottir I; Steingrimsdottir L
Br J Nutr; 2015 Jul; 114(2):248-56. PubMed ID: 26079168
[TBL] [Abstract][Full Text] [Related]
15. Change in plasma levels of vitamin D after consumption of cod-liver and fresh cod-liver oil as part of the traditional north Norwegian fish dish "Mølje".
Brustad M; Sandanger T; Wilsgaard T; Aksnes L; Lund E
Int J Circumpolar Health; 2003 Mar; 62(1):40-53. PubMed ID: 12725340
[TBL] [Abstract][Full Text] [Related]
16. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Derakhshandi H; Etemadifar M; Feizi A; Abtahi SH; Minagar A; Abtahi MA; Abtahi ZA; Dehghani A; Sajjadi S; Tabrizi N
Acta Neurol Belg; 2013 Sep; 113(3):257-63. PubMed ID: 23250818
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
[TBL] [Abstract][Full Text] [Related]
18. Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.
McDowell TY; Amr S; Culpepper WJ; Langenberg P; Royal W; Bever C; Bradham DD
Neuroepidemiology; 2011; 37(1):52-7. PubMed ID: 21822026
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D intake and incidence of multiple sclerosis.
Munger KL; Zhang SM; O'Reilly E; Hernán MA; Olek MJ; Willett WC; Ascherio A
Neurology; 2004 Jan; 62(1):60-5. PubMed ID: 14718698
[TBL] [Abstract][Full Text] [Related]
20. Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Bjørnevik K; Riise T; Cortese M; Holmøy T; Kampman MT; Magalhaes S; Myhr KM; Wolfson C; Pugliatti M
Mult Scler; 2016 Jan; 22(1):104-11. PubMed ID: 26014605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
